Clinical Trials Logo

Clinical Trial Summary

Coughing during emergence from general anaesthesia may lead to dangerous effects including laryngospasm, detrimental haemodynamic changes. Post-thyroidectomy bleeding occurs in 1-4% of patients, and severe coughing may cause bleeding. Dexmedetomidine, a potent α adrenoreceptor agonist, is theoretically appropriate for reducing airway and haemodynamic reflexes during emergence from anaesthesia.

In this study, we investigated whether intravenous single-dose dexmedetomidine at the end of surgery reduces coughing during extubation after thyroidectomy.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01774305
Study type Interventional
Source Yonsei University
Contact
Status Completed
Phase Phase 4
Start date December 2012
Completion date June 2013

See also
  Status Clinical Trial Phase
Completed NCT02932397 - Efficacy of Propofol vs Placebo in the Prevention of Coughing During Emergence of General Anesthesia Under Desflurane N/A
Completed NCT01754220 - Open-label Study of the Effects of Montelukast in Patients With Chronic Cough Phase 4
Completed NCT01368809 - Effect of Fentanyl on Coughing and Recovery After Anesthesia With an LMA Laryngeal Mask Airway)for Airway Management Phase 4
Completed NCT01774292 - Effect of Intracuff Alkalinized Lidocaine on Coughing Incidence at Extubation Phase 4
Completed NCT01518439 - Instrumental and Manual Increase of Couch in Neuromuscular Patients N/A
Recruiting NCT02303600 - Fractional Concentration of Exhaled NO(FENO) to Direct Montelukast Treatment of Sub-acute Cough N/A
Suspended NCT02655562 - Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough Phase 4